Shattuck Labs to Present Virtually at Cowen 4th Annual IO Next Summit
AUSTIN, TX and DURHAM, NC, Nov. 06, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
AUSTIN, TX and DURHAM, NC, Nov. 06, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
– Manuscript highlights the importance of molecular surveillance of SARS-CoV-2 immune evasion and rational design…
– Live video webcast with the Cocrystal management team, on Thursday, November 12th at 12:00…
ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (“Emisphere” or the “Company”)…
Active Biotech AB (publ) (ticker: ACTI) hereby invites analysts, investors and media to its virtual…
First Gene Therapy Candidate OCU400 On Track to Enter the Clinic in 2021 MALVERN, Pa.,…
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company…
Aleafia Health Port Perry Outdoor cannabis cultivation. TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Aleafia…
– Financing led by Ping An Capital – – Phase 2 SPARTA Trial for APL-101…
EnACT study of MAT2203 in cryptococcal meningitis received unanimous Data and Safety Monitoring Board (DSMB)…
SAN FRANCISCO, Nov. 06, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that…
-On track to begin enrollment in the Phase 1 trial for JTX-8064 by year-end 2020-…
MENLO PARK, Calif. and BOSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq:…
FARMINGTON HILLS, Mich., Nov. 06, 2020 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc., a clinical-stage ophthalmic…
Reports Net Revenues of $83.4 Million for the Three Months Ended September 30, 2020 RANCHO…
Reported Net Product Sales of $34.3 Million Non-GAAP Net Product Sales of $33.7 Million; Increased…
National Medical Products Administration (NMPA) granted Drug Approval License to Basilea’s partner CR Gosun Basilea…
The Phase III trial investigating canakinumab plus standard of care (SoC) did not meet its…
Merger completed with Rexahn Pharmaceuticals creating a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage…
BRIDGEWATER, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…